Skip to main content
. 2022 Jul 8;106(1):67. doi: 10.5334/jbsr.2714

Table 2.

Demographic characteristics, comorbidities, treatments, outcomes, laboratory, and radiological findings of the participants.


MEDIAN (IQR) OR N (%)

Age (years) 55.00 (35.00–68.00)

Lymphocyte (103/μL) 1.37 (1.01–1.93)

D-dimer (ng/mL) 394.00 (199.25–1017.50)

C reactive protein (mg/L) 23.90 (6.00–75.20)

Fibrinogen (mg/dL) 487.00 (366.00–614.00)

Ferritin (ng/mL) 166.34 (76.51–403.04)

Lactate dehydrogenase (U/L) 402.00 (324.00–546.00)

Gender Male 563 (62.9)

Female 332 (37.1)

Diabetes Mellitus 172 (19.2)

Hypertension 283 (31.6)

Heart Failure 45 (5.0)

Cardiovascular disease 106 (11.8)

Chronic kidney disease 28 (3.1)

Chronic obstructive pulmonary disease 61 (6.8)

Asthma 39 (4.4)

Other Pulmonary Disease 11 (1.2)

Cancer 37 (4.1)

Stroke 26 (2.9)

Hydroxycloroquine 854 (95.4)

Favipravir 238 (26.6)

Azithromycin 645 (72.1)

Convalescent plasma 21 (2.39)

Lopinavir/ritonavir 63 (7.0)

Tocilizumab 24 (2.7)

Corticosteroid 50 (5.6)

SARS CoV-2 PCR Negative 434 (48.5)

Positive 461 (51.5)

Chest CT Negative 262 (29.3)

Positive 633 (70.7)

CO-RADS 1 188 (21.0)

2 74 (8.3)

3 87 (9.7)

4 101 (11.3)

5 445 (49.7)

PCR and CT PCR:– and CT:– 112 (12.5)

PCR:+ and CT:– 150 (16.8)

PCR:- and CT:+ 322 (36.0)

PCR:+ and CT:+ 311 (34.7)

Mortality 84 (9.4)

Need for ICU 135 (15.1)

Need for IMV in ICU 92 (68.7)

IQR: Interquartile Range, PCR: Polymerase Chain Reaction, CT: Computerized Tomography, CO-RADS: COVID-19 Reporting and Data System, ICU: Intensive care unit, IMV: Invasive mechanical ventilation.